Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palbociclib and Cetuximab in KRAS/NRAS/BRAF Wild-type Metastatic Colorectal Cancer
NCT03446157Phase 2Completed
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Start
- Mar 2018
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of palbociclib in colorectal cancer (CRC), sponsored by UNC Lineberger Comprehensive Cancer Center. Started Mar 2018; status: completed.
02
Drugs
palbociclib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT03446157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03446157.